ArticleNarra J2024

Psoriasis vulgaris patient with psoriatic arthritis managed with interleukin-17A inhibitor: Balancing benefits and adverse effects.

Wina S Utama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.